COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,676 Articles (22,913 medRxiv, 8,763 bioRxiv)

Most recent first Previous |  Page 389: Articles 3881-3890  | Next

Characterization of SARS-CoV-2 Convalescent Patients' Serological Repertoire Reveals High Prevalence of Iso-RBD Antibodies
Curtis, N. C., Shin, S., Hederman, A. P., Connor, R. I., Wieland-Alter, W. F., Ionov, S., Boylston, J., Rose, J., Sakharkar, M., Dorman, D. B., Dessaint, J. A., Gwilt, L. L., Crowley, A. R., Feldman, J., Hauser, B. M., Schmidt, A. G., Ashare, A., Walker, L. M., Wright, P. F., Ackerman, M. E., Lee, J.
10.1101/2023.09.08.556349 — Posted: 2023-09-11
A Network Analysis of Molecular Interactions to Study the Development of New-onset Diabetes and Hypertension after COVID-19 Infection Using Bioinformatics Tools.
de Oliveira Andrade, L. J., Matos de Oliveira, L. C., Matos de Oliveira, G. C., Matos de Oliveira, L.
10.1101/2023.09.10.23295323 — Posted: 2023-09-11
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
Bolland, W., Michel, V., Planas, D., Hubert, M., Guivel-Benhassine, F., Porrot, F., Staropoli, I., N'Debi, M., Rodriguez, C., Fourati, S., Prot, M., Planchais, C., Hocqueloux, L., Simon-Loriere, E., Mouquet, H., Prazuck, T., Pawlotsky, J.-M., Bruel, T., Schwartz, O., Buchrieser, J.
10.1101/2023.09.06.556548 — Posted: 2023-09-11
Pre-dominance of dengue non-cross-reacting SARS-CoV-2 spike antibodies during the Omicron era and their role in the ADE-mediated surge of Dengue virus serotype 3
Sarker, S., Dutta, C., Mallick, A., Das, S., Das Chowdhury, C., De, A., Gorai, S., Biswas, S.
10.1101/2023.09.08.23295136 — Posted: 2023-09-10
Change in body weight of older adults before and during the COVID-19 pandemic: Longitudinal results from the Berlin Aging Study II
Vetter, V. M., Drewelies, J., Duezel, S., Homann, J., Meyer-Arndt, L., Braun, J., Pohrt, A., Kendel, F., Wagner, G. G., Thiel, A., Bertram, L., Regitz-Zagrosek, V., Gerstorf, D., Demuth, I.
10.1101/2023.09.08.23295246 — Posted: 2023-09-10
Ventilation during COVID-19 in a school for students with intellectual and developmental disabilities (IDD).
Zand, M. S., Spallina, S., Ross, A., Zandi, K., Pawlowski, A., Seplaki, C., Herington, J., Corbett, A., Kaukeinen, K., Freedman, E., Holden-Wiltse, J., Alcantara, L., Li, D., Cameron, A., Beaumont, N., Dozier, A., Dewhurst, S., Foxe, J.
10.1101/2023.09.08.23295268 — Posted: 2023-09-10
Prevalence and predictors of self-medication for COVID-19 among slum dwellers in Jinja City, Uganda
Nakito, P., Kisakye, A. N., Walekhwa, A. W., Tumukunde, G., Mutesi, C., Muhumuza, N., Nyamor, C., Musoke, D., Musinguzi, G., Byonanebye, D. M.
10.1101/2023.09.08.23295267 — Posted: 2023-09-09
Quantity of SARS-CoV-2 RNA copies exhaled per minute during natural breathing over the course of COVID-19 infection
Lane, G., Zhou, G., Hultquist, J. F., Simons, L. M., Lorenzo-Redondo, R., Ozer, E. A., McCarthy, D. M., Ison, M. G., Achenbach, C. J., Wang, X., Wai, C. M., Wyatt, E., Aalsburg, A., Yang, Q., Noto, T., Alisoltani, A., Ysselstein, D., Awatramani, R., Murphy, R., Theron, G., Zelano, C.
10.1101/2023.09.06.23295138 — Posted: 2023-09-08
Effect of the 2022 COVID-19 booster vaccination campaign in 50 year olds in England: regression discontinuity analysis in OpenSAFELY
Schaffer, A. L., Hulme, W. J., Horne, E. M. F., Parker, E. P. K., Walker, V., Stables, C., Mehrkar, A., Bacon, S. C. J., Bates, C., Goldacre, B., Walker, A. J., The OpenSAFELY Collaborative, , Hernan, M. A., Sterne, J. A. C.
10.1101/2023.09.07.23295194 — Posted: 2023-09-08
Effectiveness of BNT162b2 COVID-19 Vaccination in Children Aged 5-17 Years in the United States
Ogilvie, R. P., Layton, J. B., Lloyd, P. C., Jiao, Y., Djibo, D. A., Wong, H. L., Gruber, J. F., Parambi, R., Deng, J., Miller, M., Song, J., Weatherby, L. B., Peetluk, L., Lo, A.-C., Matuska, K., Wernecke, M., Bui, C. L., Clarke, T. C., Cho, S., Bell, E. J., Yang, G., Amend, K. L., Forshee, R. A., Anderson, S. A., McMahill-Walraven, C. N., Chillarige, Y., Anthony, M. S., Seeger, J. D., Shoaibi, A.
10.1101/2023.09.06.23294426 — Posted: 2023-09-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).